{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:56:26Z","timestamp":1789638986706,"version":"4.0.0"},"reference-count":81,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008385","name":"Fondazione per la Ricerca sulla Fibrosi Cistica","doi-asserted-by":"publisher","award":["FFC#9\/2018"],"award-info":[{"award-number":["FFC#9\/2018"]}],"id":[{"id":"10.13039\/501100008385","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>In cystic fibrosis (CF), the accumulation of viscous lung secretions rich in DNA and actin is a major cause of chronic inflammation and recurrent infections leading to airway obstruction. Mucolytic therapy based on recombinant human DNase1 reduces CF mucus viscosity and promotes airway clearance. However, the marked susceptibility to actin inhibition of this enzyme prompts the research of alternative treatments that could overcome this limitation. Within the human DNase repertoire, DNase1L2 is ideally suited for this purpose because it exhibits metal-dependent endonuclease activity on plasmid DNA in a broad range of pH with acidic optimum and is minimally inhibited by actin. When tested on CF artificial mucus enriched with actin, submicromolar concentrations of DNase1L2 reduces mucus viscosity by 50% in a few seconds. Inspection of superimposed model structures of DNase1 and DNase1L2 highlights differences at the actin-binding interface that justify the increased resistance of DNase1L2 toward actin inhibition. Furthermore, a PEGylated form of the enzyme with preserved enzymatic activity was obtained, showing interesting results in terms of activity. This work represents an effort toward the exploitation of natural DNase variants as promising alternatives to DNase1 for the treatment of CF lung disease.<\/jats:p>","DOI":"10.3390\/biom11030410","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T13:27:20Z","timestamp":1615382840000},"page":"410","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Actin-Resistant DNase1L2 as a Potential Therapeutics for CF Lung Disease"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6835-6367","authenticated-orcid":false,"given":"Danila","family":"Delfino","sequence":"first","affiliation":[{"name":"Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, 43124 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, 43124 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Rivetti","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, 43124 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9679-0083","authenticated-orcid":false,"given":"Antonella","family":"Grigoletto","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Bizzotto","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6472-1403","authenticated-orcid":false,"given":"Cristian","family":"Cavozzi","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, 43124 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5668-0787","authenticated-orcid":false,"given":"Marco","family":"Malatesta","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, 43124 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Cavazzini","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, 43124 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8754-0899","authenticated-orcid":false,"given":"Gianfranco","family":"Pasut","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8452-1062","authenticated-orcid":false,"given":"Riccardo","family":"Percudani","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, 43124 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1183\/09031936.00228013","article-title":"CFTR: Cystic fibrosis and beyond","volume":"44","author":"Mall","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1164\/ajrccm.154.5.8912731","article-title":"Cystic fibrosis","volume":"154","author":"Davis","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1164\/rccm.200505-840OE","article-title":"Cystic fibrosis since 1938","volume":"173","author":"Davis","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1183\/09031936.93.03010019","article-title":"The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputum","volume":"3","author":"Lethem","year":"1990","journal-title":"Eur. Respir. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1126\/science.8310295","article-title":"Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin","volume":"263","author":"Vasconcellos","year":"1994","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/rccm.200304-505SO","article-title":"Pathophysiology and management of pulmonary infections in cystic fibrosis","volume":"168","author":"Gibson","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","article-title":"ECFS best practice guidelines: The 2018 revision","volume":"17","author":"Castellani","year":"2018","journal-title":"J. Cyst. Fibros."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"9188","DOI":"10.1073\/pnas.87.23.9188","article-title":"Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum","volume":"87","author":"Shak","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group","volume":"331","author":"Fuchs","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2165\/00063030-200519030-00001","article-title":"The use of human deoxyribonuclease (rhDNase) in the management of cystic fibrosis","volume":"19","author":"Suri","year":"2005","journal-title":"BioDrugs"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/hmg\/4.9.1557","article-title":"A muscle-specific DNase I-like gene in human Xq28","volume":"4","author":"Parrish","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0378-1119(95)00741-5","article-title":"Cloning of a gene encoding a DNase I-like endonuclease in the human Xq28 region","volume":"168","author":"Pergolizzi","year":"1996","journal-title":"Gene"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1006\/geno.1997.4748","article-title":"Identification, localization, and expression of two novel human genes similar to deoxyribonuclease I","volume":"42","author":"Rodriguez","year":"1997","journal-title":"Genomics"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Laskowski, M. (1971). 12 Deoxyribonuclease I. Hydrolysis, Elsevier.","DOI":"10.1016\/S1874-6047(08)60372-8"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Moore, S. (1981). 15 Pancreatic DNase. Biology of Aminoacyl-tRNA Synthetases, Elsevier.","DOI":"10.1016\/S1874-6047(08)60341-8"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1016\/S0021-9258(18)93208-4","article-title":"Deoxyribonucleic acid nucleases. II. The effects of metals on the mechanism of action of deoxyribonuclease I","volume":"243","author":"Melgar","year":"1968","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0005-2787(73)90054-3","article-title":"Studies on bovine pancreatic deoxyribonuclease A","volume":"312","author":"Junowicz","year":"1973","journal-title":"Biochim. Biophys. Acta Nucleic Acids Protein Synth."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1021\/bi001041a","article-title":"Characterization of human DNase I family endonucleases and activation of DNase gamma during apoptosis","volume":"40","author":"Shiokawa","year":"2001","journal-title":"Biochemistry"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1042\/bj20040046","article-title":"Expression pattern of the deoxyribonuclease 1 gene: Lessons from the Dnase1 knockout mouse","volume":"380","author":"Napirei","year":"2004","journal-title":"Biochem. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2017.06.028","article-title":"Dnases in health and disease","volume":"429","author":"Keyel","year":"2017","journal-title":"Dev. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ygeno.2004.02.003","article-title":"Characterization of the human DNAS1L2 gene and the molecular mechanism for its transcriptional activation induced by inflammatory cytokines","volume":"84","author":"Shiokawa","year":"2004","journal-title":"Genomics"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/sj.jid.5700503","article-title":"DNase1L2 degrades nuclear DNA during corneocyte formation","volume":"127","author":"Fischer","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/jid.2011.13","article-title":"Essential role of the keratinocyte-specific endonuclease DNase1L2 in the removal of nuclear DNA from hair and nails","volume":"131","author":"Fischer","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/j.1365-2133.2007.07886.x","article-title":"DNase1L2 suppresses biofilm formation by Pseudomonas aeruginosa and Staphylococcus aureus","volume":"156","author":"Eckhart","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1073\/pnas.71.12.4742","article-title":"Actin is the naturally occurring inhibitor of deoxyribonuclease I","volume":"71","author":"Lazarides","year":"1974","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1365-2710.1999.00245.x","article-title":"rhDNase therapy for the treatment of cystic fibrosis patients with mild to moderate lung disease","volume":"24","author":"Christopher","year":"1999","journal-title":"J. Clin. Pharm Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s004310050046","article-title":"DNase use in the daily care of cystic fibrosis: Who benefits from it and to what extent? Results of a cohort study of 199 patients in 13 centres. DNase National Study Group","volume":"159","author":"Cobos","year":"2000","journal-title":"Eur. J. Pediatr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"8225","DOI":"10.1073\/pnas.93.16.8225","article-title":"Engineering actin-resistant human DNase I for treatment of cystic fibrosis","volume":"93","author":"Ulmer","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1164\/ajrccm.163.5.2005002","article-title":"Improved activity of an actin-resistant DNase I variant on the cystic fibrosis airway secretions","volume":"163","author":"Zahm","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","article-title":"PEGylation, successful approach to drug delivery","volume":"10","author":"Veronese","year":"2005","journal-title":"Drug Discov. Today"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1042\/CS20180315","article-title":"Impact of PEGylation on the mucolytic activity of recombinant human deoxyribonuclease I in cystic fibrosis sputum","volume":"132","author":"Guichard","year":"2018","journal-title":"Clin. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jconrel.2020.10.034","article-title":"Biodistribution and elimination pathways of PEGylated recombinant human deoxyribonuclease I after pulmonary delivery in mice","volume":"329","author":"Mahri","year":"2021","journal-title":"J. Control. Release"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2014.05.021","article-title":"PEGylation of antibody fragments greatly increases their local residence time following delivery to the respiratory tract","volume":"187","author":"Koussoroplis","year":"2014","journal-title":"J. Control. Release"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1093\/bioinformatics\/btm404","article-title":"Clustal W and Clustal X version 2.0","volume":"23","author":"Larkin","year":"2007","journal-title":"Bioinformatics"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"W320","DOI":"10.1093\/nar\/gku316","article-title":"Deciphering key features in protein structures with the new ENDscript server","volume":"42","author":"Robert","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1101\/gr.849004","article-title":"WebLogo: A sequence logo generator","volume":"14","author":"Crooks","year":"2004","journal-title":"Genome Res."},{"key":"ref_38","unstructured":"Gupta, R., Jung, E., and Brunak, S. (2021, January 31). Prediction of N-glycosylation Sites in Human Proteins. Available online: http:\/\/www.cbs.dtu.dk\/services\/NetNGlyc\/."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nprot.2008.197","article-title":"Protein structure homology modeling using SWISS-MODEL workspace","volume":"4","author":"Bordoli","year":"2009","journal-title":"Nat. Protoc."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Walker, J.M. (2005). Protein identification and analysis tools on the expasy server. The Proteomics Protocols Handbook, Humana Press.","DOI":"10.1385\/1592598900"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1093\/nar\/7.6.1513","article-title":"A rapid alkaline extraction procedure for screening recombinant plasmid DNA","volume":"7","author":"Birnboim","year":"1979","journal-title":"Nucleic Acids Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0076-6879(83)00059-2","article-title":"A rapid alkaline extraction method for the isolation of plasmid DNA","volume":"Volume 100","author":"Birnboim","year":"1983","journal-title":"Recombinant DNA Part B"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1021\/acs.biomac.5b01480","article-title":"Pegylated Polyaspartamide-Polylactide-Based Nanoparticles Penetrating Cystic Fibrosis Artificial Mucus","volume":"17","author":"Craparo","year":"2016","journal-title":"Biomacromolecules"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Ueki, M., Takeshita, H., Utsunomiya, N., Chino, T., Oyama, N., Hasegawa, M., Kimura-Kataoka, K., Fujihara, J., Iida, R., and Yasuda, T. (2017). Survey of single-nucleotide polymorphisms in the gene encoding human deoxyribonuclease I-like 2 producing loss of function potentially implicated in the pathogenesis of parakeratosis. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0175083"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1002\/jcp.29583","article-title":"Pichia pastoris: A highly successful expression system for optimal synthesis of heterologous proteins","volume":"235","author":"Karbalaei","year":"2020","journal-title":"J. Cell Physiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1470-8744.1999.tb00770.x","article-title":"Glycosylation of Pichia pastoris-derived proteins","volume":"30","author":"Bretthauer","year":"1999","journal-title":"Biotechnol. Appl. Biochem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0022-2836(86)90280-9","article-title":"Crystallographic refinement and structure of DNase I at 2 A resolution","volume":"192","author":"Oefner","year":"1986","journal-title":"J. Mol. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0003-9861(58)90280-7","article-title":"On the mechanism of metal activation of deoxyribonuclease I","volume":"73","author":"Wiberg","year":"1958","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1085\/jgp.45.4.93","article-title":"Activation of deoxyribonucleases by divalent cations","volume":"45","author":"Desreux","year":"1962","journal-title":"J. Gen. Physiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/thx.2006.060814","article-title":"Role of magnesium in the failure of rhDNase therapy in patients with cystic fibrosis","volume":"61","author":"Sanders","year":"2006","journal-title":"Thorax"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.addr.2008.09.011","article-title":"Extracellular barriers in respiratory gene therapy","volume":"61","author":"Sanders","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"10250","DOI":"10.1021\/bi300873f","article-title":"The structure of human DNase I bound to magnesium and phosphate ions points to a catalytic mechanism common to members of the DNase I-like superfamily","volume":"51","author":"Parsiegla","year":"2012","journal-title":"Biochemistry"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"16083","DOI":"10.1073\/pnas.2634339100","article-title":"Abnormal surface liquid pH regulation by cultured cystic fibrosis bronchial epithelium","volume":"100","author":"Coakley","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"C741","DOI":"10.1152\/ajpcell.00379.2005","article-title":"Hyperacidity of secreted fluid from submucosal glands in early cystic fibrosis","volume":"290","author":"Song","year":"2006","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature11130","article-title":"Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung","volume":"487","author":"Pezzulo","year":"2012","journal-title":"Nature"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.devcel.2020.07.002","article-title":"Acidic submucosal gland ph and elevated protein concentration produce abnormal cystic fibrosis mucus","volume":"54","author":"Xie","year":"2020","journal-title":"Dev. Cell"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1016\/S0021-9258(19)85765-4","article-title":"The effect of divalent cations on the mode of action of DNase I. The initial reaction products produced from covalently closed circular DNA","volume":"255","author":"Campbell","year":"1980","journal-title":"J. Biol. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0021-9258(19)41672-4","article-title":"The essential role of Ca2+ in the activity of bovine pancreatic deoxyribonuclease","volume":"250","author":"Price","year":"1975","journal-title":"J. Biol. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1110\/ps.20402","article-title":"The distinctive functions of the two structural calcium atoms in bovine pancreatic deoxyribonuclease","volume":"11","author":"Chen","year":"2002","journal-title":"Protein Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1182\/blood.V81.10.2750.2750","article-title":"Mechanisms for actin reorganization in chemotactic factor-activated polymorphonuclear leukocytes","volume":"81","author":"Watts","year":"1993","journal-title":"Blood"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev.bb.21.060192.000405","article-title":"Structure and function of actin","volume":"21","author":"Kabsch","year":"1992","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11095-009-9991-2","article-title":"Inhalable antibiotic delivery using a dry powder co-delivering recombinant deoxyribonuclease and ciprofloxacin for treatment of cystic fibrosis","volume":"27","author":"Yang","year":"2010","journal-title":"Pharm. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/thorax.55.9.795","article-title":"Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease","volume":"55","author":"Thomas","year":"2000","journal-title":"Thorax"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"W252","DOI":"10.1093\/nar\/gku340","article-title":"SWISS-MODEL: Modelling protein tertiary and quaternary structure using evolutionary information","volume":"42","author":"Biasini","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/347037a0","article-title":"Atomic structure of the actin: DNase I complex","volume":"347","author":"Kabsch","year":"1990","journal-title":"Nature"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"18374","DOI":"10.1074\/jbc.273.29.18374","article-title":"Improved potency of hyperactive and actin-resistant human DNase I variants for treatment of cystic fibrosis and systemic lupus erythematosus","volume":"273","author":"Pan","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.1021\/bi962960x","article-title":"Engineering hyperactive variants of human deoxyribonuclease I by altering its functional mechanism","volume":"36","author":"Pan","year":"1997","journal-title":"Biochemistry"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"11701","DOI":"10.1074\/jbc.273.19.11701","article-title":"Hyperactivity of human DNase I variants. Dependence on the number of positively charged residues and concentration, length, and environment of DNA","volume":"273","author":"Pan","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0022-2836(92)91064-V","article-title":"X-ray structure of the DNase I-d(GGTATACC)2 complex at 2.3 A resolution","volume":"226","author":"Weston","year":"1992","journal-title":"J. Mol. Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0021-9258(18)91875-2","article-title":"Effect of divalent cations on the reduction and re-formation of the disulfide bonds of deoxyribonuclease","volume":"244","author":"Price","year":"1969","journal-title":"J. Biol. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1110\/ps.03438204","article-title":"Biological functions of the disulfides in bovine pancreatic deoxyribonuclease","volume":"13","author":"Chen","year":"2004","journal-title":"Protein Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1110\/ps.8.9.1780","article-title":"Ca2+-dependent activity of human DNase I and its hyperactive variants","volume":"8","author":"Pan","year":"1999","journal-title":"Protein Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of pegylation on pharmaceuticals","volume":"2","author":"Harris","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Grigoletto, A., Tedeschini, T., Canato, E., and Pasut, G. (2020). The evolution of polymer conjugation and drug targeting for the delivery of proteins and bioactive molecules. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., e1689.","DOI":"10.1002\/wnan.1689"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"9726","DOI":"10.1002\/anie.200803526","article-title":"Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that \u201cslip\u201d through the human mucus barrier","volume":"47","author":"Wang","year":"2008","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/anie.201208556","article-title":"Use of single-site-functionalized PEG dendrons to prepare gene vectors that penetrate human mucus barriers","volume":"52","author":"Kim","year":"2013","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Chakraborti, S., Chakraborti, T., and Dhalla, N.S. (2017). Role of proteases in lung disease: A brief overview. Proteases in Human Diseases, Springer.","DOI":"10.1007\/978-981-10-3162-5"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/biot.201400115","article-title":"PEGylation of lysine residues improves the proteolytic stability of fibronectin while retaining biological activity","volume":"9","author":"Zhang","year":"2014","journal-title":"Biotechnol. J."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijpharm.2017.02.021","article-title":"PEGylation prolongs the pulmonary retention of an anti-IL-17A Fab\u2019 antibody fragment after pulmonary delivery in three different species","volume":"521","author":"Freches","year":"2017","journal-title":"Int. J. Pharm."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1023\/A:1016281925554","article-title":"The pulmonary absorption of aerosolized and intratracheally instilled rhG-CSF and monoPEGylated rhG-CSF","volume":"12","author":"Niven","year":"1995","journal-title":"Pharm. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"9637","DOI":"10.1021\/bi9711487","article-title":"Gelsolin activates DNase I in vitro and cystic fibrosis sputum","volume":"36","author":"Davoodian","year":"1997","journal-title":"Biochemistry"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/11\/3\/410\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:33:38Z","timestamp":1760160818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/11\/3\/410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,10]]},"references-count":81,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["biom11030410"],"URL":"https:\/\/doi.org\/10.3390\/biom11030410","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,10]]}}}